465 related articles for article (PubMed ID: 15854229)
1. Human T-cell leukemia virus type I (HTLV-I) infection and the onset of adult T-cell leukemia (ATL).
Matsuoka M
Retrovirology; 2005 Apr; 2():27. PubMed ID: 15854229
[TBL] [Abstract][Full Text] [Related]
2. Human T-cell leukemia virus type I induces adult T-cell leukemia: from clinical aspects to molecular mechanisms.
Yasunaga J; Matsuoka M
Cancer Control; 2007 Apr; 14(2):133-40. PubMed ID: 17387298
[TBL] [Abstract][Full Text] [Related]
3. Switching and loss of cellular cytokine producing capacity characterize in vivo viral infection and malignant transformation in human T- lymphotropic virus type 1 infection.
Kagdi H; Demontis MA; Ramos JC; Taylor GP
PLoS Pathog; 2018 Feb; 14(2):e1006861. PubMed ID: 29444188
[TBL] [Abstract][Full Text] [Related]
4. Differential patterns of serum biomarkers of immune activation in human T-cell lymphotropic virus type I-associated myelopathy/tropical spastic paraparesis, and adult T-cell leukemia/lymphoma.
Giusti RM; Maloney EM; Hanchard B; Morgan OS; Steinberg SM; Wachter H; Williams E; Cranston B; Fuchs D; Manns A
Cancer Epidemiol Biomarkers Prev; 1996 Sep; 5(9):699-704. PubMed ID: 8877061
[TBL] [Abstract][Full Text] [Related]
5. Adult T-cell leukemia-lymphoma as a viral disease: Subtypes based on viral aspects.
Nosaka K; Matsuoka M
Cancer Sci; 2021 May; 112(5):1688-1694. PubMed ID: 33630351
[TBL] [Abstract][Full Text] [Related]
6. [HTLV-I and leukemogenesis].
Yasunaga J; Matsuoka M
Uirusu; 2006 Dec; 56(2):241-9. PubMed ID: 17446673
[TBL] [Abstract][Full Text] [Related]
7. The human T-cell leukemia virus type 1 (HTLV-1): new insights into the clinical aspects and molecular pathogenesis of adult T-cell leukemia/lymphoma (ATLL) and tropical spastic paraparesis/HTLV-associated myelopathy (TSP/HAM).
Shuh M; Beilke M
Microsc Res Tech; 2005 Nov; 68(3-4):176-96. PubMed ID: 16276549
[TBL] [Abstract][Full Text] [Related]
8. Modulation of innate immune responses during human T-cell leukemia virus (HTLV-1) pathogenesis.
Olière S; Douville R; Sze A; Belgnaoui SM; Hiscott J
Cytokine Growth Factor Rev; 2011 Aug; 22(4):197-210. PubMed ID: 21924945
[TBL] [Abstract][Full Text] [Related]
9. Experimental acute adult T cell leukemia-lymphoma is associated with thymic atrophy in human T cell leukemia virus type I infection.
Simpson RM; Zhao TM; Hubbard BS; Sawasdikosol S; Kindt TJ
Lab Invest; 1996 Mar; 74(3):696-710. PubMed ID: 8600320
[TBL] [Abstract][Full Text] [Related]
10. Tumor immunity against adult T-cell leukemia.
Kannagi M; Harashima N; Kurihara K; Ohashi T; Utsunomiya A; Tanosaki R; Masuda M; Tomonaga M; Okamura J
Cancer Sci; 2005 May; 96(5):249-55. PubMed ID: 15904464
[TBL] [Abstract][Full Text] [Related]
11. [Etiopathogenesis and therapeutic trends in adult T-cell leukemia associated with HTLV-I retrovirus].
D'Onofrio C; Bonmassar E
Clin Ter; 1992 Feb; 140(2):155-67. PubMed ID: 1373677
[TBL] [Abstract][Full Text] [Related]
12. Human T-cell leukemia virus type I at age 25: a progress report.
Matsuoka M; Jeang KT
Cancer Res; 2005 Jun; 65(11):4467-70. PubMed ID: 15930259
[TBL] [Abstract][Full Text] [Related]
13. Clinical course of human T-lymphotropic virus type I carriers with molecularly detectable monoclonal proliferation of T lymphocytes: defining a low- and high-risk population.
Ikeda S; Momita S; Kinoshita K; Kamihira S; Moriuchi Y; Tsukasaki K; Ito M; Kanda T; Moriuchi R; Nakamura T
Blood; 1993 Oct; 82(7):2017-24. PubMed ID: 8400254
[TBL] [Abstract][Full Text] [Related]
14. Animals Models of Human T Cell Leukemia Virus Type I Leukemogenesis.
Niewiesk S
ILAR J; 2016; 57(1):3-11. PubMed ID: 27034390
[TBL] [Abstract][Full Text] [Related]
15. Adult T-cell leukemia: future prophylaxis and immunotherapy.
Kannagi M; Harashima N; Kurihara K; Utsunomiya A; Tanosaki R; Masuda M
Expert Rev Anticancer Ther; 2004 Jun; 4(3):369-76. PubMed ID: 15161436
[TBL] [Abstract][Full Text] [Related]
16. Impaired Tax-specific T-cell responses with insufficient control of HTLV-1 in a subgroup of individuals at asymptomatic and smoldering stages.
Shimizu Y; Takamori A; Utsunomiya A; Kurimura M; Yamano Y; Hishizawa M; Hasegawa A; Kondo F; Kurihara K; Harashima N; Watanabe T; Okamura J; Masuda T; Kannagi M
Cancer Sci; 2009 Mar; 100(3):481-9. PubMed ID: 19154412
[TBL] [Abstract][Full Text] [Related]
17. [Clinical and experimental study of 9 cases of adult T cell leukemia].
Hu J; Lu L; Chen Y
Zhonghua Xue Ye Xue Za Zhi; 1999 Feb; 20(2):73-5. PubMed ID: 11601202
[TBL] [Abstract][Full Text] [Related]
18. Activation of HTLV-I long terminal repeat by apoptosis inducing agents: mechanism and implications for HTLV-I pathogenicity (review).
Schavinsky-Khrapunsky Y; Gold E; Ben-Aroya Z; Torgeman A; Aboud M; Huleihel M
Int J Mol Med; 2003 Jan; 11(1):3-11. PubMed ID: 12469209
[TBL] [Abstract][Full Text] [Related]
19. [Human T-cell leukemia virus type I and adult T-cell leukemia-lymphoma].
Shimoyama M
Gan To Kagaku Ryoho; 1990 Apr; 17(4 Pt 1):589-600. PubMed ID: 2181940
[TBL] [Abstract][Full Text] [Related]
20. Human T cell leukemia virus type I-induced disease: pathways to cancer and neurodegeneration.
Barmak K; Harhaj E; Grant C; Alefantis T; Wigdahl B
Virology; 2003 Mar; 308(1):1-12. PubMed ID: 12706085
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
